Evidence map›Paper›PMID 27222468›Full record

ArticlemBio2016

Staphylococcus aureus Protein A Mediates Interspecies Interactions at the Cell Surface of Pseudomonas aeruginosa.

Catherine R Armbruster, Daniel J Wolter, Meenu Mishra, Hillary S Hayden, Matthew C Radey, Gennifer Merrihew, Michael J MacCoss, Jane Burns, Daniel J Wozniak, Matthew R Parsek and 1 more

Open access · goldAbstract read
In one paragraph

Article in mBio, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 73 papers.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

73 citing papers in PubMed, 113 citations in OpenAlex.

  1. Review
  2. Review
  3. The effect ofiScience · 2026
    Article
  4. Article
  5. Nasal Microbiota Associated with the Lung Radiomic Features in Asthma.International journal of general medicine · 2026
    Article
  6. Microbial and host innate immune factors affecting the persistence ofFrontiers in cellular and infection microbiology · 2026
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Polymicrobial interactions betweenbioRxiv : the preprint server for biology · 2024
    Article
  14. Article
  15. Review
  16. NorA efflux pump mediatesAntimicrobial agents and chemotherapy · 2024
    Article
  17. A bacterial pigment provides cross-species protection from HProceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  18. Article
  19. Article
  20. Review

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Catherine R ArmbrusterDepartment of Microbiology, University of Washington, Seattle, Washington, USA.
Daniel J WolterDepartment of Pediatrics, University of Washington, Seattle, Washington, USA.
Meenu MishraDepartment of Microbial Infection and Immunity, The Ohio State University, Columbus, Ohio, USA.
Hillary S HaydenDepartment of Microbiology, University of Washington, Seattle, Washington, USA.
Matthew C RadeyDepartment of Microbiology, University of Washington, Seattle, Washington, USA.
Gennifer MerrihewDepartment of Genome Sciences, University of Washington, Seattle, Washington, USA.
Michael J MacCossDepartment of Genome Sciences, University of Washington, Seattle, Washington, USA.
Jane BurnsDepartment of Pediatrics, University of Washington, Seattle, Washington, USA.
Daniel J WozniakDepartment of Microbial Infection and Immunity, The Ohio State University, Columbus, Ohio, USA.
Matthew R ParsekDepartment of Microbiology, University of Washington, Seattle, Washington, USA lhoffman@uw.edu parsem@uw.edu.
Lucas R HoffmanDepartment of Microbiology, University of Washington, Seattle, Washington, USA Department of Pediatrics, University of Washington, Seattle, Washington, USA lhoffman@uw.edu parsem@uw.edu.
University of Washington · USThe Ohio State University · US

Funding

Translational Research Center to Expedite Novel Therapies in Cystic FibrosisP30DK089507 · NIDDK · SEATTLE CHILDREN'S HOSPITAL · PI Christopher Hooper Goss · 2010 to 2026
$21.4M
TRAINING IN MOLECULAR AND CELLULAR BIOLOGYT32GM007270 · NIGMS · UNIVERSITY OF WASHINGTON · PI RAIBLE, DAVID W · 1985 to 2020
$21.0M
TrainingP41GM103533 · NIGMS · UNIVERSITY OF WASHINGTON · PI MACCOSS, MICHAEL · 2012 to 2021
$20.7M
Pseudomonas biofilms and immunityR01AI097511 · NIAID · OHIO STATE UNIVERSITY · PI WOZNIAK, DANIEL J · 2013 to 2017
$1.9M
Pseudomonas aeruginosa Adaptation During Early CF Airway Infection and TreatmentR01HL098084 · NHLBI · UNIVERSITY OF WASHINGTON · PI HOFFMAN, LUCAS R · 2009 to 2012
$1.6M
Conserved complement binding to bacterial porinsR21AI113462 · NIAID · OHIO STATE UNIVERSITY · PI WOZNIAK, DANIEL J · 2014 to 2015
$424k
Pseudomonas Aeruginosa Early CF Adaptive Changes: A Translational StudyK02HL105543 · NHLBI · UNIVERSITY OF WASHINGTON · PI HOFFMAN, LUCAS R · 2011 to 2014
$400k
NHLBI NIH HHS K02 HL105543NHLBI NIH HHS R01 HL098084NIAID NIH HHS R01 AI097511NIAID NIH HHS R21 AI113462NIDDK NIH HHS P30 DK089507NIGMS NIH HHS P41 GM103533NIGMS NIH HHS T32 GM007270
6 · The paper itself

Abstract

unlabelledWhile considerable research has focused on the properties of individual bacteria, relatively little is known about how microbial interspecies interactions alter bacterial behaviors and pathogenesis. Staphylococcus aureus frequently coinfects with other pathogens in a range of different infectious diseases. For example, coinfection by S. aureus with Pseudomonas aeruginosa occurs commonly in people with cystic fibrosis and is associated with higher lung disease morbidity and mortality. S. aureus secretes numerous exoproducts that are known to interact with host tissues, influencing inflammatory responses. The abundantly secreted S. aureus staphylococcal protein A (SpA) binds a range of human glycoproteins, immunoglobulins, and other molecules, with diverse effects on the host, including inhibition of phagocytosis of S. aureus cells. However, the potential effects of SpA and other S. aureus exoproducts on coinfecting bacteria have not been explored. Here, we show that S. aureus-secreted products, including SpA, significantly alter two behaviors associated with persistent infection. We found that SpA inhibited biofilm formation by specific P. aeruginosa clinical isolates, and it also inhibited phagocytosis by neutrophils of all isolates tested. Our results indicate that these effects were mediated by binding to at least two P. aeruginosa cell surface structures-type IV pili and the exopolysaccharide Psl-that confer attachment to surfaces and to other bacterial cells. Thus, we found that the role of a well-studied S. aureus exoproduct, SpA, extends well beyond interactions with the host immune system. Secreted SpA alters multiple persistence-associated behaviors of another common microbial community member, likely influencing cocolonization and coinfection with other microbes. IMPORTANCE: Bacteria rarely exist in isolation, whether on human tissues or in the environment, and they frequently coinfect with other microbes. However, relatively little is known about how microbial interspecies interactions alter bacterial behaviors and pathogenesis. We identified a novel interaction between two bacterial species that frequently infect together-Staphylococcus aureus and Pseudomonas aeruginosa We show that the S. aureus-secreted protein staphylococcal protein A (SpA), which is well-known for interacting with host targets, also binds to specific P. aeruginosa cell surface molecules and alters two persistence-associated P. aeruginosa behaviors: biofilm formation and uptake by host immune cells. Because S. aureus frequently precedes P. aeruginosa in chronic infections, these findings reveal how microbial community interactions can impact persistence and host interactions during coinfections.

Indexed as

Microbial InteractionsBiofilmsCoculture TechniquesCystic FibrosisFimbriae, BacterialHumansNeutrophilsPhagocytosisPolysaccharides, BacterialProtein BindingPseudomonas aeruginosaPseudomonas InfectionsStaphylococcal InfectionsStaphylococcal Protein AStaphylococcus aureusSurface Propertiesexopolysaccharide, PseudomonasPolysaccharides, BacterialStaphylococcal Protein A

Identifiers

PMID27222468
PMCPMC4895107
OpenAlexW2401617566

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.